{
  "results": [
    {
      "score": 85,
      "verdict": "pass",
      "rationale": "The answer correctly provides the dose, frequency, max daily mg, and volume with acceptable rounding. It cites allowed chunks and covers all clinically substantive fields.",
      "question_id": "q001",
      "question": "5-year-old (18 kg) with acute otitis media. What is the amoxicillin dose and volume using 400 mg/5 mL suspension?"
    },
    {
      "score": 0,
      "verdict": "manual_review",
      "rationale": "Judge response not JSON: ```json\n{\n  \"score\": 85,\n  \"verdict\": \"pass\",\n  \"rationale\": \"The answer correctly provides the dose, volume, frequency,...",
      "question_id": "q002",
      "question": "12 kg child with fever: acetaminophen dose and volume using 160 mg/5 mL?"
    },
    {
      "score": 75,
      "verdict": "manual_review",
      "rationale": "The answer correctly identifies the dose, volume, frequency, and max daily mg, but the rounding rule is incorrectly stated as 'whole mL' instead of '6 mL'. The notes contain a claim about using oral suspension, which is not directly supported by the cited chunks.",
      "question_id": "q003",
      "question": "12 kg child with fever: ibuprofen dose and volume using 100 mg/5 mL?"
    },
    {
      "score": 75,
      "verdict": "manual_review",
      "rationale": "The answer correctly identifies the dose of apixaban as 2.5 mg BID and cites the appropriate chunk for dose reduction criteria. However, it fails to mention the interaction with strong CYP3A4/P-gp inhibitors, which is a critical safety point. The max daily mg is correctly stated as 5 mg, but the rounding rule is not applicable here. Overall, the answer is mostly correct but lacks completeness in safety considerations.",
      "question_id": "q004",
      "question": "Elderly patient with nonvalvular AF: 82 years, 58 kg, SCr 1.6 mg/dL. What apixaban dose?"
    },
    {
      "score": 85,
      "verdict": "pass",
      "rationale": "The answer correctly provides the enoxaparin dose of 85 mg SC q12h, cites appropriate evidence chunks, and covers the required key points.",
      "question_id": "q005",
      "question": "85 kg adult with acute DVT: What is the enoxaparin treatment dose (normal renal function)?"
    },
    {
      "score": 70,
      "verdict": "manual_review",
      "rationale": "The model correctly identifies metformin as contraindicated at eGFR <30, but it only cites one allowed chunk and misses coverage for the recommendation to avoid initiation at eGFR 30–45 and the need to reduce and monitor if continuing. Additionally, it does not mention the hepatic impairment contraindication, which is critical.",
      "question_id": "q006",
      "question": "Type 2 diabetes patient with eGFR 28 mL/min/1.73 m². Can we use metformin?"
    },
    {
      "score": 85,
      "verdict": "pass",
      "rationale": "The model correctly advises against nitrofurantoin use with eGFR <30, cites appropriate chunks, and provides rationale for the contraindication.",
      "question_id": "q007",
      "question": "Uncomplicated cystitis: Should we use nitrofurantoin if eGFR is 25?"
    },
    {
      "score": 85,
      "verdict": "pass",
      "rationale": "The model correctly identifies the major interaction and appropriate actions, citing the allowed chunk. All key points are covered.",
      "question_id": "q008",
      "question": "Patient on warfarin needs TMP-SMX for UTI. Any interaction and what should we do?"
    },
    {
      "score": 70,
      "verdict": "manual_review",
      "rationale": "The model correctly identifies the major interaction and cites the appropriate chunk, but it fails to explicitly mention the mechanism and action in the notes as required. The notes imply the action but do not clearly state it, leading to a deduction for evidence coverage.",
      "question_id": "q009",
      "question": "Patient on atorvastatin needs clarithromycin. What’s the risk and action?"
    },
    {
      "score": 0,
      "verdict": "manual_review",
      "rationale": "Judge response not JSON: ```json\n{\n  \"score\": 80,\n  \"verdict\": \"manual_review\",\n  \"rationale\": \"The model correctly identifies the major interact...",
      "question_id": "q010",
      "question": "Starting linezolid in a patient on sertraline. Is this safe?"
    },
    {
      "score": 75,
      "verdict": "manual_review",
      "rationale": "The model correctly identifies the interaction and cites the appropriate chunk, but it lacks specific details on the mechanism and severity of the interaction, which are critical for completeness.",
      "question_id": "q011",
      "question": "Patient on digoxin will start amiodarone. What’s the interaction management?"
    },
    {
      "score": 80,
      "verdict": "manual_review",
      "rationale": "The model correctly abstains and cites an allowed chunk, but it does not explicitly state the reason for abstention as required, which affects the completeness of the response.",
      "question_id": "q012",
      "question": "COVID-19 patient asks for Paxlovid dosing and interaction checks."
    },
    {
      "score": 85,
      "verdict": "pass",
      "rationale": "The model correctly abstained from providing current guidelines, recognized the outdated nature of JNC8, and cited the appropriate chunk. Recency risk was flagged.",
      "question_id": "q013",
      "question": "What is the current first-line pharmacologic therapy per latest hypertension guidelines?"
    }
  ],
  "summary": {
    "mean_score": 66.92307692307692,
    "median_score": 75,
    "count": 13
  }
}
